Hi Buckland … the >us$2.5b was in reference to Relyvrio owner, and their peak capitalisation, and was referring to PAA post approval, because our initial data suggest we have a superior product.
Big pharma probably wouldn’t get involved yet because sample is too small, if they do then you may be happy, but it means MT has had to give a lot of upside away to get them involved. He may have soft interest from BP, but it’s not in the best interests of shareholders, ie. We will pay for your P2 for 75%, would you be happy? If you’re reviewing acquisitions opportunities for BP, as an employee, you don’t take punts with the company balance sheet, because your job will be no longer, pay up when there is certainty. Pay 3 x revenue when it’s a certainty and you’ll get a fantastic bonus.
ODD was MT being clever in my opinion, he got the ball rolling thinking 50/50 they may need more data, but the data addition could potentially be just an amended to the application, rather than initiating a new one and the whole 90 day process. MT has played this game before, and is very experienced with regulators and trials.
- Forums
- ASX - By Stock
- NUZ
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1039
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $111.9M |
Open | High | Low | Value | Volume |
23.0¢ | 24.5¢ | 23.0¢ | $289.4K | 1.231M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 149248 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 6664 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 115077 | 0.230 |
2 | 19129 | 0.225 |
8 | 342355 | 0.220 |
8 | 732990 | 0.215 |
2 | 80585 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 6664 | 2 |
0.240 | 110234 | 4 |
0.245 | 269236 | 4 |
0.250 | 316054 | 6 |
0.260 | 180162 | 3 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online